- Conditions
- Acne Vulgaris
- Interventions
- Botulinum Neurotoxin Type A, Bacteriostatic saline
- Drug
- Lead sponsor
- DeNova Research
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Jun 28, 2018 · Synced May 22, 2026, 5:44 AM EDT